Advanced Search

 

Study ID Status Title Patient Level Data
ADC109043 Completed An evaluation of the prevalence of airway obstruction consistent with chronic obstructive pulmonary disease (COPD) in subjects with a history of cigarette smoking and symptoms of chronic bronchitis in a primary care setting
ADERE ADULT Completed A randomized, parallel group, open study to evaluate the impact of additional guidance provided by health care professionals on treatment compliance among asthmatic patients with persistent asthma (ADERE)
ADERE PEDIATRIC 1 Completed Prospective, parallel-group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticaso ...
ADF104070 Completed An open label study of adefovir dipivoxil for the treatment of patients with chronic hepatitis B related advanced fibrosis or cirrhosis.
ADF105220 Completed Phase III study of Adefovir Dipivoxil tablets in patients with compensated chronic hepatitis B -Comparative study against Lamivudine-
ADF106632 Completed A 2-year multi-centre, open-label, local phase IV study to demonstrate the efficacy and safety of adefovir dipivoxil tablets (10mg) in Chinese subjects with HBe antigen negative Chronic Hepatitis B
ADF108005 Completed A phase IV, open label, single arm, multicenter, extension study of adefovir dipivoxil for Korean patients with chronic hepatitis B(CHB) who have completed ADF 103814
ADF108356 Completed A 48-week multi-centre, open-label, local phase IV study to demonstrate the efficacy and safety of adefovir dipivoxil tablets (10mg) in Chinese subjects with compensated Chronic Hepatitis B
ADF20001 Completed Open label compassionate access programme to provide adefovir dipivoxil to patients with chronic hepatitis B infection.
ADF30001 Completed A Multi-Centre, Double-Blind , Randomized, Placebo-Controlled Phase II/III Study of Adefovir Dipivoxil for the Treatment of Chinese Patients with HBeAg positive Chronic Hepatitis B Followed by Long-term (5 Years total) Adefovir Dipivoxil Treatment. (Report on Year 1 and Year 2 Data)
ADF30001 (Year 1 to Year 4) Completed A Multi-Center, Double-Blind , Randomized, Placebo-Controlled Phase II/III Study of Adefovir Dipivoxil for the Treatment of ChinesePatients with HBeAg positive Chronic Hepatitis B Followed by Long-term (5 Years total) Adefovir Dipivoxil Treatment. (Report on data outto 4 years)
ADF30001_3 Completed A Multi-Center, Double-Blind , Randomized, Placebo-Controlled Phase II/III Study of Adefovir Dipivoxil for theTreatment of Chinese Patients with HBeAg positive Chronic Hepatitis B Followed by Long-term (5 Years total)Adefovir Dipivoxil Treatment. (Report on interim data out to 3 years)
ADF30001_5 Completed A multicentre double blind randomised placebo controlled phase II/III study of adefovir dipivoxil for the treatment of Chinese patients with HBeAg positive chronic hepatitis B.
ADF30002 Completed Clinical Evaluation of Adefovir Dipivoxil [GW284873X] in Patients with chronic hepatitis B (including cirrhosis B) who have signs of clinical deterioration associated with the replication of YMDD variant HBV following lamivudine therapy
ADF30003 Completed Clinical evaluation of adefovir dipivoxil (GW284873X) in patients with chronic hepatitis B (including cirrhosis B) who have signs of clinical deterioration associated with the replication of YMDD variant HBV following lamivudine therapy – A follow-up long-term study of ADF30002 (a 16-week, open ...
ADG103440 Completed A randomised,double-blind, parallel group, placebo-controlled, multicentre study to evaluate the safety, tolerability and efficacy of oral GW677954 capsules 2.5mg, 5mg, 10mg and 20mg a day for 24 weeks in overweight dyslipidaemic subjects Study Listed on ClinicalStudyDataRequest.com
ADG20001 Completed A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of Oral GW677954 as a Monotherapy for 12 Weeks Duration in Patients with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
AK110016 Completed Final study report for a randomized, single-dose, three-way crossover study examining the bioequivalence of a reformulated WELLBUTRIN SR 100 mg tablet formulation versus the currently-marketed WELLBUTRIN SR 100 mg tablet formulation in healthy volunteers.
AK110021 Completed Single-Center, Randomized, Double-Blind, Placebo-Controlled, Four-Week Study to Assess the Safety of Multiple Fixed Doses of WELLBUTRIN SR (bupropion hydrochloride sustained release) Tablets in Outpatients with Untreated Stage I Hypertension Study Listed on ClinicalStudyDataRequest.com
AK110022 Completed An open-label, randomized, single-dose, two-way crossover study examining the bioequivalence of one newly formulated WELLBUTRIN SR† 200mg tablet versus two currently marketed WELLBUTRIN SR 100mg tablets in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
AK1102364 Completed Clinical evaluation of 323U66 SR in patients with depression - Open-Label study -
AK1102365 Completed Clinical evaluation of 323U66 SR in patients with depression - Placebo-controlled, double-blind, comparative study in patients with depression who did not respond sufficiently to selective serotonin re-uptake inhibitors
AK1102369 Completed Clinical Evaluation of 323U66 SR in patients with Depression – Investigation in Elderly patients with Depression –
AK130926 Completed A Multicenter, Double-Blind, Randomized, Placebo Controlled Comparison of the Effects on Sexual Functioning of Extended-Release Bupropion Hydrochloride (300-450mg) and escitalopram (10-20mg) in Outpatients with Moderate to Severe Major Depression over an Eight-Week Treatment Period
AK130927 Completed A Multicenter, Double-blind Randomized Placebo-controlled Comparison of the Effects on Sexual Functioning of Extended-release Bupropion Hydrochloride (300-450mg) and Escitalopram (10-20mg) in Outpatients with Moderate to Severe Major Depression over an Eight-Week Treatment Period

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.